10x Genomics, Inc. (TXG) Free cash flow 2017–2025
10x Genomics, Inc. (TXG) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$130.1MFY2025 · since FY2017: -$14.5M → $130.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $130.1M | +2371.2% |
| FY2024 | -$5.7M | +91.0% |
| FY2023 | -$63.8M | +61.4% |
| FY2022 | -$165.3M | -34.7% |
| FY2021 | -$122.7M | +51.8% |
| FY2020 | -$254.6M | -3037.0% |
| FY2019 | -$8.1M | +90.2% |
| FY2018 | -$82.7M | -472.1% |
| FY2017 | -$14.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice